The Application and Consideration of Patient-reported Outcomes

doi:10.12114/j.issn.1007-9572.2020.00.015

Abstract

Abstract: The research and development of patient-reported outcomes （PROs） in China are slow，which needs to be vigorously carried out and promoted to improve the quality of medical services and improve people's health and well-being.This is a review of the research progress of PROs at home and abroad，with a view to providing references for related clinical research and health management.Based on PROs at home and abroad in recent years the literature analysis and summary，this paper introduced the concept，classification and content，the selection of scale，the making and implementation of Patient-reported outcomes，as well as its general situation of the main application.We also proposed the problem of PROs development in our country and put forward related suggestions.

Key words: Patient-reported outcomes, Outcome assessment （health care）, Review

摘要： 我国患者报告结局（PROs）的研究和发展缓慢，需要大力开展和推广，有助于改善医疗服务质量，提高人民的健康福祉。本文综述PROs的国内外研究进展，以期为相关的临床研究和卫生管理提供参考。通过对近年来PROs的国内外文献进行分析和总结，论述了PROs的概念，分类和内容，量表的选择、制作和实施，以及主要的应用概况，探讨了我国PROs发展所存在的问题并提出了相关的建议。

关键词: 患者报告结局, 结果评价（卫生保健）, 综述

LONG Lizhi,YUAN Ling. The Application and Consideration of Patient-reported Outcomes　[J]. Chinese General Practice, 2020, 23(32): 4120-4127. DOI: 10.12114/j.issn.1007-9572.2020.00.015.
隆莉芝,袁玲. 患者报告结局的应用近况及思考[J]. 中国全科医学, 2020, 23(32): 4120-4127. DOI: 10.12114/j.issn.1007-9572.2020.00.015.

References

［1］COONS S J，GWALTNEY C J，HAYS R D，et al．Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome （PRO） measures：ISPOR ePRO Good Research Practices Task Force report［J］．Value Health，2009，12（4）：419-429．DOI：10.1111/j.1524-4733.2008.00470.x.
［2］MCCOLL E，JUNGHARD O，WIKLUND I，et al．Assessing symptoms in gastroesophageal reflux disease：how well do clinicians' assessments agree with those of their patients?［J］．Am J Gastroenterol，2005，100（1）：11-18．DOI：10.1111/j.1572-0241.2005.40945.x.
［3］HAREENDRAN A，GNANASAKTHY A，WINNETTE R，et al．Capturing patients' perspectives of treatment in clinical trials/drug development［J］．Contemp Clin Trials，2012，33（1）：23-28．DOI：10.1016/j.cct.2011.09.015.
［4］Center for Drug Evaluation and Research （CDER），Center for Biologics Evaluation and Research （CBER），Center for Devices and Radiological Health （CDRH）.Guidance for industry patient-reported outcome measures：use in medical product development to support labeling claims［EB/OL］．（2009-12-01）［2018-07-22］．https：//www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims.
［5］HIGGINS J P T，GREEN S.Cochrane Handbook for systematic reviews of interventions version 5.1.0［EB/OL］．（2011-03-01）［2018-07-23］．https：//training.cochrane.org/handbook/archive/v5.1/.
［6］European Medicines Agency.Reflection paper on the regulatory guidance for the use of health related quality of life （HRQL） measures in the evaluation of medicinal products［EB/OL］．（2005-07-27）［2018-05-23］．http：//www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf.
［7］WILLKE R J，BURKE L B，ERICKSON P.Measuring treatment impact：a review of patient-reported outcomes and other efficacy endpoints in approved product labels［J］．Control Clin Trials，2004，25（6）：535-552．DOI：10.1016/j.cct.2004.09.003.
［8］WELDRING T，SMITH S M.Patient-reported outcomes （PROs） and patient-reported outcome measures （PROMs）［J］．Health Serv Insights，2013，6：61-68．DOI：10.4137/HSI.S11093.
［9］KYTE D G，CALVERT M，VAN DER WEES P J，et al．An introduction to patient-reported outcome measures （PROMs） in physiotherapy［J］．Physiotherapy，2015，101（2）：119-125．DOI：10.1016/j.physio.2014.11.003.
［10］Department of Health.Guidance on the routine collection of patient reported outcome measures （PROMs）［J］．Department of Health，2009.
［11］Nationella Kvalitetsregister.National quality registry for knee arthroplasty［EB/OL］．［2018-05-19］．http：//www.kvalitetsregister.se/englishpages/findaregistry/registerarkivenglish/nationalqualityregistryforkneearthroplasty.2190.html#kontakt.
［12］BLACK N.Patient reported outcome measures could help transform healthcare［J］．BMJ，2013，346：f167．DOI：10.1136/bmj.f167.
［13］李娜.比较电子化和传统纸质病人报告结局在神经科学临床研究中的应用［D］．上海：复旦大学，2012.
［14］MUEHLHAUSEN W，DOLL H，QUADRI N，et al．Equivalence of electronic and paper administration of patient-reported outcome measures：a systematic review and meta-analysis of studies conducted between 2007 and 2013［J］．Health Qual Life Outcomes，2015，13：167．DOI：10.1186/s12955-015-0362-x.
［15］JAMISON R N，RAYMOND S A，LEVINE J G，et al．Electronic diaries for monitoring chronic pain：1-year validation study［J］．Pain，2001，91（3）：277-285．DOI：10.1016/s0304-3959（00）00450-4.
［16］STOKES T，PATY J.Electronic diaries，part 2：the role of the clinical protocol in developing and implementing electronic diaries［J/OL］．Applied Clinical Trials，（2003-03-01）［2018-06-09］．http：//www.appliedclinicaltrialsonline.com/electronic-diaries-part-2-role-clinical-protocol-developing-and-implementing-electronic-diaries.
［17］刘衍波.电子化和传统纸质病人报告的临床结局数据质量的比较［D］．上海：复旦大学，2013.
［18］刘砚燕，陈如男，姚静静，等．患者报告结局的国内外研究进展［J］．现代预防医学，2013，40（12）：2268-2271，2279.
［19］ACQUADRO C，BERZON R，DUBOIS D，et al．Incorporating the patient's perspective into drug development and communication：an ad hoc task force report of the Patient-Reported Outcomes （PRO） Harmonization Group meeting at the Food and Drug Administration，February 16，2001［J］．Value Health，2003，6（5）：522-531．DOI：10.1046/j.1524-4733.2003.65309.x.
［20］MACEFIELD R C，JACOBS M，KORFAGE I J，et al．Developing core outcomes sets：methods for identifying and including patient-reported outcomes （PROs）［J］．Trials，2014，15：49．DOI：10.1186/1745-6215-15-49.
［21］MARQUIS P，ARNOULD B，ACQUADRO C，et al．Patient-reported outcomes and health-related quality of life in effectiveness studies：pros and cons［J］．Drug Development Research，2006，67：193-201．DOI：10.1002/ddr.20077.
［22］SAWATZKY R，CHAN E K H，ZUMBO B D，et al．Montreal accord on patient-reported outcomes （PROs） use series-paper 7：modern perspectives of measurement validation emphasize justification of inferences based on patient reported outcome scores［J］．J Clin Epidemiol，2017，89：154-159．DOI：10.1016/j.jclinepi.2016.12.002.
［23］SCHIFFERDECKER K E，YOUNT S E，KAISER K，et al．A method to create a standardized generic and condition-specific patient-reported outcome measure for patient care and healthcare improvement［J］．Qual Life Res，2018，27（2）：367-378．DOI：10.1007/s11136-017-1675-5.
［24］CELLA D，HAHN E A，JENSEN S E，et al．Patient-reported outcomes in performance measurement［J］．NC：RTI Press，2015．DOI：10.3768/rtipress.2015.bk.0014.1509.
［25］CHE HAMZAH J，BURR J M，RAMSAY C R，et al．Choosing appropriate patient-reported outcomes instrument for glaucoma research：a systematic review of vision instruments［J］．Qual Life Res，2011，20（7）：1141-1158．DOI：10.1007/s11136-010-9831-1.
［26］COONS S J，RAO S，KEININGER D L，et al．A comparative review of generic quality-of-life instruments［J］．Pharmacoeconomics，2000，17（1）：13-35．DOI：10.2165/00019053-200017010-00002.
［27］GHOLAMI A，JAHROMI L M，ZAREI E，et al．Application of WHOQOL-BREF in measuring quality of life in health-care staff［J］．Int J Prev Med，2013，4（7）：809-817.
［28］WARE J E Jr，GANDEK B.Overview of the SF-36 Health Survey and the International Quality of Life Assessment （IQOLA） Project［J］．J Clin Epidemiol，1998，51（11）：903-912．DOI：10.1016/s0895-4356（98）00081-x.
［29］AARONSON N K，AHMEDZAI S，BERGMAN B，et al．The European Organization for Research and Treatment of Cancer QLQ-C30：a quality-of-life instrument for use in international clinical trials in oncology［J］．J Nati Cancer Inst，1993，85（5）：365-376．DOI：10.1093/jnci/85.5.365.
［30］OSTINI R，DOWER J，DONALD M.The Audit of Diabetes-Dependent Quality of Life 19 （ADDQoL）：feasibility，reliability and validity in a population-based sample of Australian adults［J］．Qual Life Res，2012，21（8）：1471-1477．DOI：10.1007/s11136-011-0043-0.
［31］CALVERT M J，FREEMANTLE N.Use of health-related quality of life in prescribing research.Part 1：why evaluate health-related quality of life?［J］．J Clin Pharm Ther，2003，28（6）：513-521．DOI：10.1046/j.0269-4727.2003.00521.x.
［32］FITZPATRICK R，DAVEY C，BUXTON M J，et al．Evaluating patient-based outcome measures for use in clinical trials［J］．Health Technol Assess，1998，2（14）：ⅰ-ⅳ，1-74.
［33］PHILPOT L M，BARNES S A，BROWN R M，et al．Barriers and benefits to the use of patient-reported outcome measures in routine clinical care：a qualitative study［J］．Am J Med Qual，2018，33（4）：359-364．DOI：10.1177/1062860617745986.
［34］EMERY M P，PERRIER L L，ACQUADRO C.Patient-reported outcome and quality of life instruments database （PROQOLID）：frequently asked questions［J］．Health Qual Life Outcomes，2005，3：12．DOI：10.1186/1477-7525-3-12.
［35］PINOTTI R.PROQOLID［J］．J Med Libr Assoc，2016，104（1）：91-92．DOI：10.3163/1536-5050.104.1.022.
［36］THORNTON A.New resource available：PROQOLID［EB/OL］．（2015-03-04）［2019-03-10］．https：//libguides.mssm.edu/blog/new-resource-available-proqolid.
［37］National Institutes of Health.Patient-Reported Outcomes Measurement Information System（PROMIS） -annoucements［EB/OL］．［2019-4-30］．https：//commonfund.nih.gov/promis/index.
［38］Northwestern University.Intro to PROMIS?［EB/OL］．［2019-4-30］．http：//www.healthmeasures.net/.
［39］BLACK N，JENKINSON C.How can patients' views of their care enhance quality improvement?［J］．BMJ（online），2009，339（7714）：202-205．DOI：10.1136/bmj.b2587.
［40］Department of Health.Guidance on the routine collection of Patient Reported Outcome Measures （PROMs）for the NHS in England［EB/OL］．（2008-12-08）［2018-07-14］．http：//webarchive.nationalarchives.gov.uk/20130107105354/http：//www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_092625.pdf.
［41］SNYDER C F，JENSEN R E，SEGAL J B，et al．Patient-reported outcomes （PROs）：putting the patient perspective in patient-centered outcomes research［J］．Med Care，2013，51（8 Suppl 3）：S73-79．DOI：10.1097/MLR.0b013e31829b1d84.
［42］LIU G，HOWELL D，PEREZ COSIO A，et al．Creation of On-PROST：the Ontario patient-reported outcomes of symptoms and toxicity applied clinical research unit［J］．J Clin Oncol，2012，30（34_suppl）：47．DOI：10.1200/jco.2012.30.34_suppl.47.
［43］HOWELL D，PEREZ COSIO A，LIU G，et al．PHP198 from science to service：the Ontario Patient Reported Outcomes of Symptoms and Toxicity （On-PROST） research unit［J］．Value Health，2012，15（7）：A324．DOI：10.1016/j.jval.2012.08.740.
［44］SNYDER C F，AARONSON N K，CHOUCAIR A K，et al．Implementing patient-reported outcomes assessment in clinical practice：a review of the options and considerations［J］．Qual Life Res，2012，21（8）：1305-1314．DOI：10.1007/s11136-011-0054-x.
［45］ZBROZEK A，HEBERT J，GOGATES G，et al．Validation of electronic systems to collect patient-reported outcome （PRO） data-recommendations for clinical trial teams：report of the ISPOR ePRO systems validation good research practices task force［J］．Value Health，2013，16（4）：480-489．DOI：10.1016/j.jval.2013.04.002.
［46］BARTLETT S J，AHMED S.Montreal Accord on Patient-Reported Outcomes （PROs） use series - Paper 1：introduction［J］．J Clin Epidemiol，2017，89：114-118．DOI：10.1016/j.jclinepi.2017.04.012.
［47］GNANASAKTHY A，MORDIN M，EVANS E，et al．A review of patient-reported outcome labeling in the United States （2011-2015）［J］．Value Health，2017，20（3）：420-429．DOI：10.1016/j.jval.2016.10.006.
［48］BANSAL D，BHAGAT A，SCHIFANO F，et al．Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe （2008-2012）［J］．J Epidemiol Glob Health，2015，5（4）：385-395．DOI：10.1016/j.jegh.2015.04.006.
［49］KLUETZ P G，O'CONNOR D J，SOLTYS K.Incorporating the patient experience into regulatory decision making in the USA，Europe，and Canada［J］．Lancet Oncol，2018，19（5）：e267-274．DOI：10.1016/S1470-2045（18）30097-4.
［50］HAREENDRAN A，ABRAHAM L.Using a treatment satisfaction measure in an early trial to inform the evaluation of a new treatment for benign prostatic hyperplasia［J］．Value Health，2005，8（Suppl 1）：S35-40．DOI：10.1111/j.1524-4733.2005.00074.x.
［51］UNGER J M，VAIDYA R，GORE J L.Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials［J］．Urol Oncol，2019，37（5）：324-330．DOI：10.1016/j.urolonc.2018.02.012.
［52］European Patients' Academy on Therapeutic Innovation.What is EUPATI?［EB/OL］．［2019-03-23］．https：//www.eupati.eu/what-is-eupati/.
［53］KYPRIOTAKIS G，VIDRINE D J，FRANCIS L E，et al．The longitudinal relationship between quality of life and survival in advanced stage cancer［J］．Psychooncology，2016，25（2）：225-231．DOI：10.1002/pon.3846.
［54］TROTTI A，COLEVAS A D，SETSER A，et al．Patient-reported outcomes and the evolution of adverse event reporting in oncology［J］．J Clin Oncol，2007，25（32）：5121-5127．DOI：10.1200/jco.2007.12.4784.
［55］BASCH E.The missing voice of patients in drug-safety reporting［J］．N Engl J Med，2010，362（10）：865-869．DOI：10.1056/NEJMp0911494.
［56］FROMME E K，EILERS K M，MORI M，et al．How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30［J］．J Clin Oncol，2004，22（17）：3485-3490．DOI：10.1200/JCO.2004.03.025.
［57］DI MAIO M，GALLO C，LEIGHL N B，et al．Symptomatic toxicities experienced during anticancer treatment：agreement between patient and physician reporting in three randomized trials［J］．J Clin Oncol，2015，33（8）：910-915．DOI：10.1200/JCO.2014.57.9334.
［58］BASCH E，IASONOS A，MCDONOUGH T，et al．Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events：results of a questionnaire-based study［J］．Lancet Oncol，2006，7（11）：903-909．DOI：10.1016/S1470-2045（06）70910-X.
［59］BASCH E，JIA X Y，HELLER G，et al．Adverse symptom event reporting by patients vs clinicians：relationships with clinical outcomes［J］．J Natl Cancer Inst，2009，101（23）：1624-1632．DOI：10.1093/jnci/djp386.
［60］QUINTEN C，MARINGWA J，GOTAY C C，et al．Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival［J］．J Natl Cancer Inst，2011，103（24）：1851-1858．DOI：10.1093/jnci/djr485.
［61］ATKINSON T M，LI Y L，COFFEY C W，et al．Reliability of adverse symptom event reporting by clinicians［J］．Qual Life Res，2012，21（7）：1159-1164．DOI：10.1007/s11136-011-0031-4.
［62］BASCH E M，REEVE B B，MITCHELL S A，et al．Electronic toxicity monitoring and patient-reported outcomes［J］．Cancer J，2011，17（4）：231-234．DOI：10.1097/PPO.0b013e31822c28b3.
［63］DUECK A C，MENDOZA T R，MITCHELL S A，et al．Validity and reliability of the US national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events （PRO-CTCAE）［J］．JAMA Oncol，2015，1（8）：1051-1059．DOI：10.1001/jamaoncol.2015.2639.
［64］KLUETZ P G，CHINGOS D T，BASCH E M，et al．Patient-reported outcomes in cancer clinical trials：measuring symptomatic adverse events with the national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events （PRO-CTCAE）［J］．Am Soc Clin Oncol Educ Book，2016，35：67-73．DOI：10.1200/EDBK_159514.
［65］British Standards Institution.Health care services-quality management systems-requirements based on En Iso 9001：2008［EB/OL］．［2019-04-09］.https：//www.galp.at/dateien/EN1522430895.pdf.
［66］FROSCH D L.Patient-reported outcomes as a measure of healthcare quality［J］．J Gen Intern Med，2015，30（10）：1383-1384．DOI：10.1007/s11606-015-3476-2.
［67］CHAWLA N，URATO M，AMBS A，et al．Unveiling SEER-CAHPS?：a new data resource for quality of care research［J］．J Gen Intern Med，2015，30（5）：641-650．DOI：10.1007/s11606-014-3162-9.
［68］BASCH E，DEAL A M，DUECK A C，et al．Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment［J］．JAMA，2017，318（2）：197-198．DOI：10.1001/jama.2017.7156.
［69］HOSTETTER M，KLEIN S.Using patient-reported outcomes to improve health care quality［EB/OL］.［2019-03-20］．https：//www.commonwealthfund.org/publications/newsletter-article/using-patient-reported-outcomes-improve-health-care-quality.
［70］DONOVAN J L，HAMDY F C，LANE J A，et al．Patient-reported outcomes after monitoring，surgery，or radiotherapy for prostate cancer［J］．N Engl J Med，2016，375（15）：1425-1437．DOI：10.1056/NEJMoa1606221.
［71］CRANDALL W，KAPPELMAN M D，COLLETTI R B，et al．Improve Care Now：the development of a pediatric inflammatory bowel disease improvement network［J］．Inflamm Bowel Dis，2011，17（1）：450-457．DOI：10.1002/ibd.21394.
［72］COOK K F，SCHALET B D.Montreal accord on patient-reported outcomes （PROs） use series-commentary［J］．J Clin Epidemiol，2017，89：111-113．DOI：10.1016/j.jclinepi.2017.04.009.
［73］曹阳，余小萍.PRO量表国内外研究近况［J］．中医杂志，2014，55（8）：710-714．DOI：10.13288/j.11-2166/r.2014.08.023.http://www.cnki.com.cn/Article/CJFDTotal-ZZYZ201408028.htm．
［74］张艳宏，刘保延，何丽云，等．基于中风痉挛性瘫痪患者报告的临床结局评价量表的信度、效度分析［J］．中医杂志，2008，49（8）：698-700.
［75］刘宏潇，姜泉，刘保延，等．基于类风湿关节炎患者报告的临床结局测量量表的初步构建［J］．中医杂志，2009，50（6）：503-506．DOI：10.3321/j.issn：1001-1668.2009.06.009.
［76］李立志，董国菊，王承龙，等．“基于心血管疾病病人报告的临床疗效评价量表”的研制及统计学分析［J］．中西医结合心脑血管病杂志，2008，6（7）：757-759．DOI：10.3969/j.issn.1672-1349.2008.07.001.
［77］唐旭东，王萍，刘保延，等．基于慢性胃肠疾病患者报告临床结局测量量表的编制及信度、效度分析［J］．中医杂志，2009，50（1）：27-29．DOI：10.3321/j.issn：1001-1668.2009.01.012.
TANG X D，WANG P，LIU B Y，et al．Development and analysis of a Patient Reported Outcome Instrument for Chronic Gastrointestinal Diseases［J］．Journal of Traditional Chinese Medicine，2009，50（1）：27-29．DOI：10.3321/j.issn：1001-1668.2009.01.012.
［78］金香兰，张允岭，韩振蕴，等．关于引入PRO理念评价中医药治疗轻度痴呆疗效的思考［J］．天津中医药，2008，25（1）：29-31.
JIN X L，ZHANG Y L，HAN Z Y，et al．Evaluation of therapeutic effect of mild dementia with introduction of patient reported outcome method［J］．Tianjin Journal of Traditional Chinese Medicine，2008，25（1）：29-31.
［79］刘保延.中医临床疗效评价研究的现状与展望［J］．中国科学基金，2010，24（5）：268-274．DOI：10.16262/j.cnki.1000-8217.2010.05.012.
LIU B Y.Present situation and prospect of the study on clinical effectiveness evaluation of tcm［J］．Bulletin of National Natural Science Foundation of China，2010，24（5）：268-274．DOI：10.16262/j.cnki.1000-8217.2010.05.012.
［80］何磊.量表在中医健康评价研究中的应用分析［D］．北京：北京中医药大学，2018.
HE L.Application analysis of scale in health evaluation of traditional Chinese medicine［D］．Beijing：Beijing University of Chinese Medicine，2018.
［81］BARTLETT S J，WITTER J，CELLA D，et al．Montreal Accord on Patient-Reported Outcomes （PROs） use series-paper 6：creating national initiatives to support development and use-the PROMIS example［J］．J Clin Epidemiol，2017，89：148-153．DOI：10.1016/j.jclinepi.2017.04.015.

[1]	Jianfeng LUO, Jiangtao HOU, Zhengkun HOU, Bin PENG, Huibiao LI, Shiying LIU, Zhenfan HE, Jiamin ZHONG, Shijing ZHANG, Fengbin LIU, Xinlin CHEN. Development and Item Selection of the Inflammatory Bowel Disease Patient-reported Outcomes Scale Based on Theories of Traditional Chinese Medicine [J]. Chinese General Practice, 2022, 25(29): 3672-3677.
[2]	LI Kexin，LYU Jing，YU Bing，LUO Haoming. Emerging Markers of Frailty in Older People: Recent Strides and Prospect　 [J]. Chinese General Practice, 2021, 24(36): 4580-4586.
[3]	REN Siqiang, ZHANG Qian, DAI Yuxi, ZHEN Xicheng. Latest Developments in Physical Fatigue Evaluation Methods in Patients with Stroke　 [J]. Chinese General Practice, 2021, 24(36): 4661-4664.
[4]	SUN Jian, MAO Xingxing, LONG Yuanyuan, SHA Mengqi, LIU Xiping, CHEN Yan, HUANG Pei. Research Progresses on the Role of Glucose-6-phosphate Dehydrogenase in Tumors　 [J]. Chinese General Practice, 2021, 24(35): 4540-4548.
[5]	HE Chunhua，WANG Jinfang，WANG Qingguo. Latest Advances in Cardiovascular Risk in Primary Hyperparathyroidism　 [J]. Chinese General Practice, 2021, 24(33): 4287-4292.
[6]	WANG Yucheng，CHEN Zhiwei，CHEN Ruizhen. Clinical Characteristics and Comprehensive Management of Heart Failure with Improved Ejection Fraction　 [J]. Chinese General Practice, 2021, 24(32): 4049-4054.
[7]	GAO Tianli. Imaging Evaluation of Vulnerable Carotid Plaques：Present Status and Future Prospect　 [J]. Chinese General Practice, 2021, 24(32): 4055-4060.
[8]	WANG Xue，ZHOU Yuqiu，LIU Dongwei，WANG Weiliang，MENG Xiangyu，ZHANG Chunyu. Recent Advances in Cognitive Impairment in Schizophrenia：Stage-specific Features and Interventions　 [J]. Chinese General Practice, 2021, 24(32): 4121-4125.
[9]	ZHU Lingyan，SHEN Yi，SHAO Yi，LIU Fen. The Role of m6A RNA Methylation Modification in Esophageal Cancer　 [J]. Chinese General Practice, 2021, 24(32): 4150-4154.
[10]	ZHOU Lulu，LU Yuan，LIU Yalin，ZHANG Hui，YU Dehua，TANG Lan. Recent Advances in Non-pharmacological Treatment of Mild Cognitive Impairment　 [J]. Chinese General Practice, 2021, 24(31): 4027-4031.
[11]	WANG Jianan，LIU Lamei，SUN Mengjie. Recent Progress on Transitional Care Assessment Tools for Older Chronic Disease Patients　 [J]. Chinese General Practice, 2021, 24(31): 4032-4036.
[12]	FAN Ziyu，FANG Xuan，ZHANG Sheng. Invasive Lobular Carcinoma of Breast：Clinicopathological Features，Current and Prospective Diagnosis and Treatment　 [J]. Chinese General Practice, 2021, 24(30): 3806-3813.
[13]	YANG Rong，LIAO Xiaoyang，LEI Yi，YUAN Mengyi. Advances in the Key Oncogene and Tumor-suppressor Gene in Early Lung Adenocarcinoma　 [J]. Chinese General Practice, 2021, 24(29): 3774-3780.
[14]	QIN Yao，ZHANG Jiajia，WU Yan，GE Xiaoyan，HAN Hongjuan，CUI Jing，BAI Wenlin，YU Hongmei. Research Progress on Reversion of Mild Cognitive Impairment to Normal Cognition　 [J]. Chinese General Practice, 2021, 24(27): 3506-3509.
[15]	HAN Jiaqi，WANG Wei. Classification and Clinical Characteristics of Adulthood Leukoencephalopathies　 [J]. Chinese General Practice, 2021, 24(27): 3510-3517.